Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

euticals Holdings Inc. stockholders' equity

$  1,872,156

1,741,591Noncontrolling interests

60,878

61,738Total stockholders' equity

$  1,933,034

1,803,329TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$  7,642,822

$  3,912,389The following table presents unaudited condensed consolidated statement of cash flow data for the six months ended June 30, 2011 and 2010:Six Months Ended
March 31,20112010OPERATING ACTIVITIES:Consolidated net income

$
35,847

$
,815Adjustments to reconcile consolidated net income to net cash provided by operating activities:Depreciation and amortization

97,739

42,955Stock-based compensation

18,772

10,391Amortization of debt issuance costs and premium / discount

14,345

11,564Other

9,366

15,475Changes in assets and liabilities which provided cash:

(61,756)

(15,844)Net cash provided by operating activities

214,313

176,356INVESTING ACTIVITIES:Purchases of property, plant and equipment, net

(23,905)

(6,166)Acquisition, net of cash acquired

(2,342,556)

—Other

(2,133)

160,951Net cash provided by (used in) investing activities

(2,368,594)

154,785FINANCING ACTIVITIES:Proceeds from debt, net of principal payments

2,426,835

—Deferred financing fees

(81,753)

—Purchase of common stock

(34,701)

(50,064)Other

(549)

2,732Net cash used in financing activities

2,309,832

(47,332)Effect of foreign exchange rate

104

—NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

155,655

283,809CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

466,214

708,462CASH AND CASH EQUIVALENTS, END OF PERIOD

$
21,869

$
992,271Safe Harbor StatementThis press release contains forward-looking stat
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the ... consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), health ... signing of its first distributor for its new Cordyceps ... Hubei Province located in the ... The contract with the new distributor, ...
(Date:7/31/2014)... -- Northsight Capital, Inc. (OTCBB: NCAP) announced today that businessman ... of the company. Mr. Bluher has extensive experience in ... investment banking. Mr. Bluher has over 15 years of ... Wall Street, Mr. Bluher was also Senior Counsel in ... Commission in Washington D.C.   ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
... April 20, 2012  In a time of rapid ... rethinking their use of technology, applications and workflow. ... for health and human services organizations nationwide, today ... help providers deliver accountable, recovery-based care in the ...
... April 20, 2012 There are some two dozen oncology ... earlier stages of development. While only some of these therapies ... yet another hurdle: a competitive marketplace where success revolves around ... environment, pharmaceutical organizations in the oncology therapeutic area must constantly ...
Cached Medicine Technology:Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 2Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 3Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 4Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector 2
(Date:7/31/2014)... Vegas, NV (PRWEB) July 31, 2014 ... to helping independent pharmacies enhance patient care by ... compliance and medication adherence. The first of many ... the opening of ThoughtSpot 2014, Good Neighbor Pharmacy ... for Medicare and Medicaid Services (CMS) Star Measures ...
(Date:7/31/2014)... 2014 The controversy surrounding uterine ... notes that Johnson & Johnson’s Ethicon, Inc. unit ... its power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) from the ... company said it decided to do so because ... remain uncertain.* , “In light of mounting evidence ...
(Date:7/31/2014)... 31, 2014 Model moms are believers. PBS ... reports positions in the field have grown exponentially in the ... any thriving industry, there are associated myths that need to ... is Frontier Nursing University . Celebrating 75 years in ... program in the nation. “Frontier is changing the face ...
(Date:7/31/2014)... Clifton Dental Associates is now proud ... fluoride treatments to their adult patients to aid in ... sensitivity in patients that exhibit symptoms. Dental caries, ... commonly known as “tooth decay” or a “cavity.” This ... , Fluoride therapy is the delivery of ...
(Date:7/31/2014)... The July 2014 issue of ... an open access journal featuring the following articles:, ... generating multicomponent , Graphene veils: A ... A workflow to increase verification rate of chromosomal ... Quantification of particle-conjugated or particle-encapsulated peptides on ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 3
... Dr. Khanna wants to thank ... in a row. , ... 2010 -- Repeat is sure sweet. Dr. Khanna and The Khanna Institute of Lasik & ... LASIK surgeon by the readers of the Ventura County Star. This achievement is notably recognized and ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
... Calif.Scientists from the California Institute of Technology (Caltech) have ... key proteingp120found on the surface of a specific subgroup ... demonstrated that a particular antibody to gp120 makes contact ... receptor that gp120 uses to gain entrance into the ...
... Treatment Service has been named a "Clinical Center of Excellence" ... upon five pain centers each year. This is the first ... are honored to be named a Clinical Center of Excellence ... chief of the pain management department at Children,s. "Everyone in ...
... too , FRIDAY, April 2 (HealthDay News) -- Death can ... own death, or that of a loved one. , Yet ... information from such talks, people can make sure that their ... followed when it,s most crucial. , "It,s very important to ...
... , ... According to a survey conducted by the Greater New England ... that they were supportive of the recently passed health care reform legislation. ... themselves and their employees. The survey also found that 61 percent ...
Cached Medicine News:Health News:Dr. Rajesh Khanna Selected as Best Lasik Surgeon Two Years in a Row 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 3Health News:Start Talking About Life's End Well in Advance 2Health News:Start Talking About Life's End Well in Advance 3Health News:Minority Businesses Support Health Care Reform Legislation, According to Survey 2
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
... Cryo System is the first in portability and performance. ... surgeons who need a flexible, portable system with the ... CTU attaches easily to an "E" size tank and ... cryo to where it is needed.,The CTU Travel Case ...
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
The most compact revolutionary innovation in hematology. 26 parameters with 5 Part DIFF...
Medicine Products: